Back to results
US 2023/0265118 A1Published application
Salt of curcumin monoglucuronide
AssigneeTherabiopharma Inc.
InventorsAtsushi IMAIZUMI, Hitomi UMETA, Yasumichi FUKUDA
Life of this patent
Estimating the term…
Abstract
Provided are a derivative of curcumin monoglucuronide excellent in solubility and chemical stability, which can be provided as pharmaceuticals, and a method for producing the same. A salt of curcumin monoglucuronide represented by Chemical Formula 1, wherein M represents a pharmaceutically acceptable cation, a hydrate thereof, or a solvate thereof.
Claims10
1:
- A salt of curcumin monoglucuronide represented by Chemical Formula 1 below,
- wherein M represents a pharmaceutically acceptable cation,
- a hydrate thereof, or a solvate thereof.
2:
- A compound according to claim 1, M being a sodium ion, a potassium ion, or an ammonium ion.
3:
- A method of preparing the compound according to claim 1, wherein a curcumin monoglucuronide is reacted with a base represented by Chemical Formula (II) below,
- Mm-Y (II)
- wherein M represents a pharmaceutically acceptable cation, Y represents an anion, and in represents an integer from 1 to 3.
4:
- The method according to claim 3, wherein M is a sodium ion, a potassium ion or an ammonium ion, Y is a hydroxide ion, and m is 1.
5:
- A pharmaceutical composition comprising the compound according to claim 1.
6:
- The pharmaceutical composition comprising a solution of the compound according to claim 5, for parenteral administration.
7-9. (canceled)
10:
- A method of treating or preventing a disease with curcumin comprising administering the composition of claim 5
11:
- The method of claim 10 wherein the pharmaceutical composition comprises an aqueous solution.
12:
- The method of claim 11 wherein the composition is administered intravenously.